🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial was originally designed and powered to compare biomarker modulat...
Status
Completed
Location
University of Pittsburgh Cancer Institute
Start Date
2005-11
Trial ID
NCT01515137
Treatments Being Tested
This randomized phase III trial is studying eflornithine and sulindac to se...
Status
Completed
Location
University of California Medical Center At Irvine-Orange Campus
Start Date
1998-07
Trial ID
NCT00118365
Treatments Being Tested
Taxotere has been approved by the FDA and is considered a standard treatmen...
Status
Completed
Location
Birmingham Hematology Oncology Associates
Start Date
2001-04
Trial ID
NCT00085826
Treatments Being Tested
This study is a multicenter, randomized, double-blind, placebo-controlled c...
Status
Recruiting
Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University
Start Date
2025-01-20
Trial ID
NCT06693362
Treatments Being Tested
The investigators hypothesize that the combination of eflornithine and suli...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2013-08-23
Trial ID
NCT01349881
The purpose of this randomized, double-blind, Phase III trial is to determi...
Status
Completed
Location
University of California San Diego
Start Date
2013-10
Trial ID
NCT01483144
Treatments Being Tested
This randomized phase II trial is studying sulindac to see how well it work...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2006-08
Trial ID
NCT00368927
The purpose of this study is to determine in a randomized, placebo-controll...
Status
Completed
Location
Huntsman Cancer Institute
Start Date
2010-04
Trial ID
NCT01187901
This is a multi-center randomized double-blind placebo controlled trial of ...
Status
Active Not Recruiting
Location
Johns Hopkins University
Start Date
2020-07-10
Trial ID
NCT04207944
Treatments Being Tested
This study is to investigate the safety, tolerability and efficacy of Sulin...
Status
Withdrawn
Location
Children's Hospital Colorado
Start Date
2022-05-25
Trial ID
NCT04823052